July 23, 2017 1:42 AM ET


Company Overview of Omrix Biopharmaceuticals, Inc.

Company Overview

Omrix Biopharmaceuticals, Inc. develops, manufactures, and markets biological products for the bio surgical and immunotherapy markets. It provides bio surgical products and product candidates, which are a fibrin sealant used as an adjunct to hemostasis in surgical procedures, and marketed as Evicel in the United States and as Quixil outside of the United States; and Evithrom, a thrombin product primarily for use in neurosurgery. The company develops biosurgical product candidates portfolio which includes Fibrin Patch, comprising Evicel components and thrombin embedded in a biodegradable device, designed for the management and rapid control of bleeding, including mild, moderate, and severe bl...

One Rockefeller Plaza

New York, NY 10020

United States

Founded in 1995

212 Employees





Key Executives for Omrix Biopharmaceuticals, Inc.

Omrix Biopharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Omrix Biopharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.